CEBON; Jonathan

Patent Applications and Registrations

Patent applications and USPTO patent grants for CEBON; Jonathan.The latest application filed is for "method of inhibiting or activating gamma delta t cells".

Company Profile

4.7.16

CEBON; Jonathan - Heidelberg Victoria
Cebon; Jonathan - Darlinghurst New South Wales
Cebon; Jonathan - New York NY
Cebon; Jonathan - Victoria N/A AU
Cebon; Jonathan - Clifton Hill AU

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method Of Inhibiting Or Activating Gamma Delta T Cells App 20220273713 - BEHREN; Andreas ; et al.	2022-09-01
Cancer stratification and treatment based on Inhibition of NOD-2 App 20220228222 - Goodnow; Christopher ; et al.	2022-07-21
Composition Of Ny-eso-1-specific T Cell Receptors Restricted On Multiple Major Histocompatibility Complex Molecules App 20210324035 - Witte; Owen N. ; et al.	2021-10-21
Method Of Treating Cancer App 20210292411 - BEHREN; Andreas ; et al.	2021-09-23
Methods for prognosis prediction for melanoma cancer Grant 10,266,902 - Black , et al.	2019-04-23
Method Of Treating Cancer App 20190023783 - BEHREN; Andreas ; et al.	2019-01-24
Devices and Methods for Prognosis Prediction for Melanoma Cancer App 20170107583 - Black; Michael Alan ; et al.	2017-04-20
Devices and methods for prognosis prediction for melanoma cancer Grant 9,534,258 - Black , et al. January 3, 2	2017-01-03
Method Of Treating Cancer App 20160376364 - BEHREN; Andreas ; et al.	2016-12-29
In Vivo Efficacy Of Ny-eso-1 Plus Adjuvant App 20160000894 - Cebon; Jonathan ; et al.	2016-01-07
Devices And Methods For Prognosis Prediction For Melanoma Cancer App 20150031578 - BLACK; MICHAEL ALAN ; et al.	2015-01-29
Prognosis prediction for melanoma cancer Grant 8,822,149 - Black , et al. September 2, 2	2014-09-02
Method for determining presence of cancer in a sample by assaying for expression of ECSA/DPPA-2 nucleotide sequences Grant 8,354,243 - John , et al. January 15, 2	2013-01-15
In Vivo Efficacy Of Ny-eso-1 Plus Adjuvant App 20120171232 - Cebon; Jonathan ; et al.	2012-07-05
Method For Modifying Celluar Immune Resonse By Modulating Activin Activity App 20100279409 - Robson; Neil ; et al.	2010-11-04
Method For Determining Presence Of Cancer In A Sample By Assaying For Expression Of Dppa-2 Nucleotide Sequences App 20100210522 - John; Thomas ; et al.	2010-08-19
Prognosis prediction for melanoma cancer App 20100136553 - Black; Michael Alan ; et al.	2010-06-03
In vivo efficacy of ny-eso-1 plus adjuvant App 20070190072 - Cebon; Jonathan ; et al.	2007-08-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.